Cargando…

Evaluation of a software module for adaptive treatment planning and re-irradiation

BACKGROUND: The aim of this work is to validate the Dynamic Planning Module in terms of usability and acceptance in the treatment planning workflow. METHODS: The Dynamic Planning Module was used for decision making whether a plan adaptation was necessary within one course of radiation therapy. The M...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Anne, Weick, Stefan, Krieger, Thomas, Exner, Florian, Kellner, Sonja, Polat, Bülent, Flentje, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745858/
https://www.ncbi.nlm.nih.gov/pubmed/29282089
http://dx.doi.org/10.1186/s13014-017-0943-4
_version_ 1783288988795142144
author Richter, Anne
Weick, Stefan
Krieger, Thomas
Exner, Florian
Kellner, Sonja
Polat, Bülent
Flentje, Michael
author_facet Richter, Anne
Weick, Stefan
Krieger, Thomas
Exner, Florian
Kellner, Sonja
Polat, Bülent
Flentje, Michael
author_sort Richter, Anne
collection PubMed
description BACKGROUND: The aim of this work is to validate the Dynamic Planning Module in terms of usability and acceptance in the treatment planning workflow. METHODS: The Dynamic Planning Module was used for decision making whether a plan adaptation was necessary within one course of radiation therapy. The Module was also used for patients scheduled for re-irradiation to estimate the dose in the pretreated region and calculate the accumulated dose to critical organs at risk. During one year, 370 patients were scheduled for plan adaptation or re-irradiation. All patient cases were classified according to their treated body region. For a sub-group of 20 patients treated with RT for lung cancer, the dosimetric effect of plan adaptation during the main treatment course was evaluated in detail. Changes in tumor volume, frequency of re-planning and the time interval between treatment start and plan adaptation were assessed. RESULTS: The Dynamic Planning Tool was used in 20% of treated patients per year for both approaches nearly equally (42% plan adaptation and 58% re-irradiation). Most cases were assessed for the thoracic body region (51%) followed by pelvis (21%) and head and neck cases (10%). The sub-group evaluation showed that unintended plan adaptation was performed in 38% of the scheduled cases. A median time span between first day of treatment and necessity of adaptation of 17 days (range 4–35 days) was observed. PTV changed by 12 ± 12% on average (maximum change 42%). PTV decreased in 18 of 20 cases due to tumor shrinkage and increased in 2 of 20 cases. Re-planning resulted in a reduction of the mean lung dose of the ipsilateral side in 15 of 20 cases. CONCLUSION: The experience of one year showed high acceptance of the Dynamic Planning Module in our department for both physicians and medical physicists. The re-planning can potentially reduce the accumulated dose to the organs at risk and ensure a better target volume coverage. In the re-irradiation situation, the Dynamic Planning Tool was used to consider the pretreatment dose, to adapt the actual treatment schema more specifically and to review the accumulated dose.
format Online
Article
Text
id pubmed-5745858
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57458582018-01-03 Evaluation of a software module for adaptive treatment planning and re-irradiation Richter, Anne Weick, Stefan Krieger, Thomas Exner, Florian Kellner, Sonja Polat, Bülent Flentje, Michael Radiat Oncol Research BACKGROUND: The aim of this work is to validate the Dynamic Planning Module in terms of usability and acceptance in the treatment planning workflow. METHODS: The Dynamic Planning Module was used for decision making whether a plan adaptation was necessary within one course of radiation therapy. The Module was also used for patients scheduled for re-irradiation to estimate the dose in the pretreated region and calculate the accumulated dose to critical organs at risk. During one year, 370 patients were scheduled for plan adaptation or re-irradiation. All patient cases were classified according to their treated body region. For a sub-group of 20 patients treated with RT for lung cancer, the dosimetric effect of plan adaptation during the main treatment course was evaluated in detail. Changes in tumor volume, frequency of re-planning and the time interval between treatment start and plan adaptation were assessed. RESULTS: The Dynamic Planning Tool was used in 20% of treated patients per year for both approaches nearly equally (42% plan adaptation and 58% re-irradiation). Most cases were assessed for the thoracic body region (51%) followed by pelvis (21%) and head and neck cases (10%). The sub-group evaluation showed that unintended plan adaptation was performed in 38% of the scheduled cases. A median time span between first day of treatment and necessity of adaptation of 17 days (range 4–35 days) was observed. PTV changed by 12 ± 12% on average (maximum change 42%). PTV decreased in 18 of 20 cases due to tumor shrinkage and increased in 2 of 20 cases. Re-planning resulted in a reduction of the mean lung dose of the ipsilateral side in 15 of 20 cases. CONCLUSION: The experience of one year showed high acceptance of the Dynamic Planning Module in our department for both physicians and medical physicists. The re-planning can potentially reduce the accumulated dose to the organs at risk and ensure a better target volume coverage. In the re-irradiation situation, the Dynamic Planning Tool was used to consider the pretreatment dose, to adapt the actual treatment schema more specifically and to review the accumulated dose. BioMed Central 2017-12-28 /pmc/articles/PMC5745858/ /pubmed/29282089 http://dx.doi.org/10.1186/s13014-017-0943-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Richter, Anne
Weick, Stefan
Krieger, Thomas
Exner, Florian
Kellner, Sonja
Polat, Bülent
Flentje, Michael
Evaluation of a software module for adaptive treatment planning and re-irradiation
title Evaluation of a software module for adaptive treatment planning and re-irradiation
title_full Evaluation of a software module for adaptive treatment planning and re-irradiation
title_fullStr Evaluation of a software module for adaptive treatment planning and re-irradiation
title_full_unstemmed Evaluation of a software module for adaptive treatment planning and re-irradiation
title_short Evaluation of a software module for adaptive treatment planning and re-irradiation
title_sort evaluation of a software module for adaptive treatment planning and re-irradiation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745858/
https://www.ncbi.nlm.nih.gov/pubmed/29282089
http://dx.doi.org/10.1186/s13014-017-0943-4
work_keys_str_mv AT richteranne evaluationofasoftwaremoduleforadaptivetreatmentplanningandreirradiation
AT weickstefan evaluationofasoftwaremoduleforadaptivetreatmentplanningandreirradiation
AT kriegerthomas evaluationofasoftwaremoduleforadaptivetreatmentplanningandreirradiation
AT exnerflorian evaluationofasoftwaremoduleforadaptivetreatmentplanningandreirradiation
AT kellnersonja evaluationofasoftwaremoduleforadaptivetreatmentplanningandreirradiation
AT polatbulent evaluationofasoftwaremoduleforadaptivetreatmentplanningandreirradiation
AT flentjemichael evaluationofasoftwaremoduleforadaptivetreatmentplanningandreirradiation